Origin Life Sciences, Inc.
PRINCETON, NJ · Founded 2010 · CIK 0001573901 · Biotech · Private
Multimodal cancer biology datasets from patient tumor tissue integrating spatial transcriptomics, morphology, proteomics, and perturbation response
origin.bio →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $2.9M
- 5 Form D · Oct 2023
- 36 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2012201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $500,000 | |
| Private capital raised | Form D · SEC | $1,332,100 | |
| Private capital raised | Form D · SEC | $500,000 | |
| Private capital raised | Form D · SEC | $500,000 | |
| Private capital raised | Form D · SEC | $51,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2143 | Calico | — | — |
| 2144 | Scinai Immunotherapeutics Ltd. | — | $3.0M |
| 2145 | ISOLERE BIO INC | — | — |
| 2146 | Origin Life Sciences, Inc. | — | $2.9M |
| 2147 | KALION, INC. | — | $6.7M |
| 2148 | VIRONGY, LLC | — | — |
| 2149 | EpiBiologics, Inc. | — | $30M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Issac Anthony IIIExecutive Officer
- Anthony BramptonDirector
- Tony BramptonDirector
- David DantzkerDirector · Executive Officer
- David Dantzker, MDDirector · Executive Officer
- Alex Dolgopolsky, MDExecutive Officer
- Alex Dolgopolsky, PhDExecutive Officer
- John FernandesExecutive Officer
- Johnny FernandesExecutive Officer
- Betsy HannaExecutive Officer
- Jerome KortenDirector
- Vic MicatiDirector
- Victor MicatiDirector
- Howard NelsonDirector · Executive Officer
- Michael PohlExecutive Officer
- Mike PohlExecutive Officer
- Michael PrestonDirector · Executive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.